[Retracted] Effects of Different Nonsteroidal Anti-Inflammatory Drugs Combined with Platelet-Rich Plasma on Inflammatory Factor Levels in Patients with Osteoarthritis

Figure 1

Comparison of VAS scores. The abscissa indicated before treatment, after 4 weeks of treatment, and after 8 weeks of treatment, and the ordinate indicated the VAS score (points). The VAS scores in the diclofenac sodium group before treatment, after 4 weeks of treatment, and after 8 weeks of treatment were (6.33 ± 1.42), (5.64 ± 1.06), and (4.01 ± 0.58) points, respectively. The VAS scores in the celecoxib group before treatment, after 4 weeks of treatment, and after 8 weeks of treatment were (6.35 ± 1.35), (4.59 ± 1.02), and (3.50 ± 0.82) points, respectively. The VAS scores in the iguratimod group before treatment, after 4 weeks of treatment, and after 8 weeks of treatment were (6.28 ± 1.41), (3.22 ± 0.97), and (2.35 ± 0.70) points, respectively. The remarkable differences in VAS scores between the diclofenac sodium group and the celecoxib group after 4 weeks and 8 weeks of treatment from left to right (t = 4.430 and 3.211, ); the remarkable differences in VAS scores between the diclofenac sodium group and the iguratimod group after 4 weeks and 8 weeks of treatment from left to right (t = 10.652 and 11.549, ); and the remarkable differences in VAS scores between the celecoxib group and the iguratimod group after 4 weeks and 8 weeks of treatment from left to right (t = 6.156 and 6.746, ).